Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
22 February 2021 |
Main ID: |
NCT03366506 |
Date of registration:
|
04/12/2017 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)
EpidALS |
Scientific title:
|
Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS) |
Date of first enrolment:
|
March 9, 2009 |
Target sample size:
|
2000 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT03366506 |
Study type:
|
Observational [Patient Registry] |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Israel
| | | | | | | |
Contacts
|
Name:
|
Marc Gotkine, MBBS |
Address:
|
|
Telephone:
|
+972507874692 |
Email:
|
marc@gotkine.com |
Affiliation:
|
|
|
Name:
|
Marc Gotkine, MBBS |
Address:
|
|
Telephone:
|
+972507874692 |
Email:
|
marc@gotkine.com |
Affiliation:
|
|
|
Name:
|
Marc Gotkine, MBBS |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
hadassah medical organisation |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Suspected, possible, probable ,definite ALS
Exclusion Criteria:
-
Age minimum:
12 Years
Age maximum:
120 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
ALS
|
Intervention(s)
|
Other: Observation
|
Primary Outcome(s)
|
Progression rate
[Time Frame: up to 10 years]
|
Secondary Outcome(s)
|
Appearance of clinical features of UMN or LMN dysfunction
[Time Frame: 10 years]
|
Secondary ID(s)
|
0633-08-HMO-CTIL
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|